Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free VMD Stock Alerts

Viemed Healthcare (VMD) Competitors

Viemed Healthcare logo
$10.45 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$10.93 +0.48 (+4.58%)
As of 09:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

VMD vs. AVAH, AHCO, TDOC, ARDT, and CDNA

Should you buy Viemed Healthcare stock or one of its competitors? MarketBeat compares Viemed Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Viemed Healthcare include Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Teladoc Health (TDOC), Ardent Health (ARDT), and CareDx (CDNA). These companies are all part of the "healthcare" industry.

How does Viemed Healthcare compare to Aveanna Healthcare?

Viemed Healthcare (NASDAQ:VMD) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

In the previous week, Aveanna Healthcare had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 2 mentions for Aveanna Healthcare and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.89 beat Aveanna Healthcare's score of 0.97 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company Overall Sentiment
Viemed Healthcare Very Positive
Aveanna Healthcare Positive

Aveanna Healthcare has a consensus price target of $10.50, suggesting a potential upside of 48.10%. Given Aveanna Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Aveanna Healthcare is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

74.2% of Viemed Healthcare shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Viemed Healthcare has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

Aveanna Healthcare has a net margin of 10.37% compared to Viemed Healthcare's net margin of 5.20%. Aveanna Healthcare's return on equity of 124.68% beat Viemed Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Viemed Healthcare5.20% 10.52% 7.60%
Aveanna Healthcare 10.37%124.68%7.07%

Aveanna Healthcare has higher revenue and earnings than Viemed Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$270.28M1.48$14.93M$0.3728.24
Aveanna Healthcare$2.43B0.63$225.03M$1.186.01

Summary

Aveanna Healthcare beats Viemed Healthcare on 12 of the 17 factors compared between the two stocks.

How does Viemed Healthcare compare to AdaptHealth?

Viemed Healthcare (NASDAQ:VMD) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Viemed Healthcare has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$270.28M1.48$14.93M$0.3728.24
AdaptHealth$3.24B0.43-$70.79M-$0.62N/A

Viemed Healthcare has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market.

Viemed Healthcare has a net margin of 5.20% compared to AdaptHealth's net margin of -2.42%. Viemed Healthcare's return on equity of 10.52% beat AdaptHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
Viemed Healthcare5.20% 10.52% 7.60%
AdaptHealth -2.42%2.76%0.99%

AdaptHealth has a consensus price target of $14.29, suggesting a potential upside of 40.61%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
AdaptHealth
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, AdaptHealth had 3 more articles in the media than Viemed Healthcare. MarketBeat recorded 4 mentions for AdaptHealth and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.89 beat AdaptHealth's score of 1.30 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company Overall Sentiment
Viemed Healthcare Very Positive
AdaptHealth Positive

74.2% of Viemed Healthcare shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Viemed Healthcare beats AdaptHealth on 9 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Viemed Healthcare has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.52-$200.32M-$0.97N/A
Viemed Healthcare$270.28M1.48$14.93M$0.3728.24

In the previous week, Teladoc Health had 5 more articles in the media than Viemed Healthcare. MarketBeat recorded 6 mentions for Teladoc Health and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.89 beat Teladoc Health's score of 0.77 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
Teladoc Health Positive
Viemed Healthcare Very Positive

Teladoc Health presently has a consensus price target of $7.43, indicating a potential upside of 1.48%. Given Teladoc Health's stronger consensus rating and higher probable upside, research analysts plainly believe Teladoc Health is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Viemed Healthcare has a net margin of 5.20% compared to Teladoc Health's net margin of -6.81%. Viemed Healthcare's return on equity of 10.52% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-6.81% -11.45% -5.54%
Viemed Healthcare 5.20%10.52%7.60%

Teladoc Health has a beta of 2.14, indicating that its stock price is 114% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

Summary

Viemed Healthcare beats Teladoc Health on 9 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Ardent Health?

Ardent Health (NYSE:ARDT) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

Ardent Health has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

In the previous week, Ardent Health had 4 more articles in the media than Viemed Healthcare. MarketBeat recorded 5 mentions for Ardent Health and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.89 beat Ardent Health's score of 1.30 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
Ardent Health Positive
Viemed Healthcare Very Positive

74.2% of Viemed Healthcare shares are held by institutional investors. 1.9% of Ardent Health shares are held by insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Ardent Health currently has a consensus target price of $14.21, suggesting a potential upside of 51.70%. Given Ardent Health's stronger consensus rating and higher possible upside, research analysts clearly believe Ardent Health is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ardent Health
2 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.36
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Ardent Health has higher revenue and earnings than Viemed Healthcare. Ardent Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ardent Health$6.32B0.21$135.81M$0.959.86
Viemed Healthcare$270.28M1.48$14.93M$0.3728.24

Viemed Healthcare has a net margin of 5.20% compared to Ardent Health's net margin of 2.09%. Ardent Health's return on equity of 13.85% beat Viemed Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Ardent Health2.09% 13.85% 4.48%
Viemed Healthcare 5.20%10.52%7.60%

Summary

Ardent Health and Viemed Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to CareDx?

Viemed Healthcare (NASDAQ:VMD) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.

74.2% of Viemed Healthcare shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by insiders. Comparatively, 2.4% of CareDx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Viemed Healthcare has a net margin of 5.20% compared to CareDx's net margin of -2.01%. Viemed Healthcare's return on equity of 10.52% beat CareDx's return on equity.

Company Net Margins Return on Equity Return on Assets
Viemed Healthcare5.20% 10.52% 7.60%
CareDx -2.01%-2.65%-1.96%

CareDx has a consensus target price of $25.00, indicating a potential upside of 8.84%. Given CareDx's higher possible upside, analysts plainly believe CareDx is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
CareDx
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, CareDx had 6 more articles in the media than Viemed Healthcare. MarketBeat recorded 7 mentions for CareDx and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.89 beat CareDx's score of 0.68 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company Overall Sentiment
Viemed Healthcare Very Positive
CareDx Positive

Viemed Healthcare has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market. Comparatively, CareDx has a beta of 2.49, suggesting that its stock price is 149% more volatile than the broader market.

Viemed Healthcare has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$270.28M1.48$14.93M$0.3728.24
CareDx$379.80M3.12-$21.35M-$0.16N/A

Summary

Viemed Healthcare beats CareDx on 9 of the 15 factors compared between the two stocks.

Get Viemed Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VMD vs. The Competition

Export
MetricViemed HealthcareMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$400.65M$8.31B$6.52B$12.05B
Dividend YieldN/A2.50%2.67%5.66%
P/E Ratio28.2415.6424.0024.42
Price / Sales1.487.00533.77123.88
Price / Cash9.0817.4427.4837.92
Price / Book2.763.6210.556.82
Net Income$14.93M$224.06M$3.57B$337.56M
7 Day Performance5.34%-1.40%0.59%1.16%
1 Month Performance11.76%4.39%1.55%3.16%
1 Year Performance57.14%-0.88%25.41%30.60%

Viemed Healthcare Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VMD
Viemed Healthcare
2.4679 of 5 stars		$10.45
flat		N/A+57.1%$400.65M$270.28M28.241,382
AVAH
Aveanna Healthcare
4.8054 of 5 stars		$6.87
+3.5%		$10.50
+52.8%		+44.4%$1.45B$2.43B5.8235,500
AHCO
AdaptHealth
4.8857 of 5 stars		$9.81
+1.7%		$14.29
+45.6%		+18.1%$1.31B$3.24BN/A10,900
TDOC
Teladoc Health
1.3656 of 5 stars		$6.96
-1.8%		$7.43
+6.9%		+6.5%$1.28B$2.53BN/A5,600
ARDT
Ardent Health
4.5131 of 5 stars		$9.39
+6.3%		$14.21
+51.3%		-28.7%$1.27B$6.32B9.8825,200

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:VMD) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel